Conakry

Resilience System


You are here

Home › U.S. FDA authorizes Novavax's COVID vaccine as booster for adults › U.S. FDA authorizes Novavax's COVID vaccine as booster for adults

U.S. FDA authorizes Novavax's COVID vaccine as booster for adults

Primary tabs

U.S. FDA authorizes Novavax's COVID vaccine as booster for adults

Wed, 2022-10-19 16:32 — mike kraft
U.S. FDA authorizes Novavax's COVID vaccine as booster for adults The U.S. Food and Drug Administration on Wednesday authorized Novavax Inc's COVID-19 vaccine as a booster for adults, helping the company's shares reverse course and rise more than 3%. Reuters Reuters

...

The authorization applies for people unable to get updated Omicron-tailored boosters, or those who would choose not to receive any other booster dose.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks